To the central content area
:::
:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

6661 WELGENE
中文
Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
CHEN FU CHIAN CHEN FU CHIAN CHEN YING JEN (02)66160001 12F., No.3, Park St., Nangang Dist.,Taipei City 115, Taiwan (R.O.C.) 2021/01/27
Industry Main Business
Biotechnology and Medical Care The R&D strategy of Welgene Biotech. has always being on the high-throughput technology platforms such as microarray and next generation sequencing and drive these technologies into clinical testing or commodities, including array-based CGH for the chromosomal aberrations, embryo implantation (Preimpantation Genetic Screening Array, PGS array) and Non-Invasive Prenatal Test (NIPT). Welgene continues to co-work with researchers to look forward to establishing more core technologies and products and developing business opportunities.
 
Market Information ( 2021/12/03 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
margin
balance
(1,000shr.)
Short
margin
balance
(1,000shr.)
19 25.00  24.40  24.40  0.00  11 0.08 N/A N/A
Trading method Fun
purchase
price or
securities
pneeded
on T day
Announcement of Irregularity
(2021/12/06)
TPEx measures
adopted
(2021/12/06)
With warrants Can be shorted or margined? Detail
Normal N N N N N Today History
 
Financial Reports
Cash Flows Items
Amount
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Balance
Sheets
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Profit
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 More detail:MOPS
 Foreign issuers’ information is disclosed in consolidated statements.